Translational Development Acquisition
TDAC | NASDAQ
$10.86
-$0.02 (-0.18%)
At close: Nov 16, 2026, 4:00 PM ET
$10.90
+$0.04 (+0.37%)
After-hours:
Nov 16, 2026, 4:10 PM ET
Translational Development Acquisition Company Profile
Company profile explainedCompany Profile
Translational Development Acquisition Corp., founded in 2022 and headquartered in New York, New York, currently conducts no significant business operations. Its primary goal is to complete a business combination, such as a merger, amalgamation, share exchange, asset acquisition, share purchase, or reorganization, with one or more companies.
Key Executives
| Name | Position |
|---|---|
| Michael Hoffman | Chairman of the Board & Chief Executive Officer |
| Avi C. Das | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 30, 2026 | 425 | Filing |
| Oct 08, 2026 | 425 | Filing |
| Sep 24, 2026 | 425 | Filing |
| Sep 14, 2026 | 425 | Filing |
| Aug 14, 2026 | 10-Q | Quarterly Report |
| Aug 14, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Aug 14, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 12, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 03, 2026 | 425 | Filing |
| Jul 28, 2026 | 425 | Filing |
Translational Development Acquisition
| Country | United States |
| IPO Date | Feb 20, 2025 |
| Industry | Shell Companies |
| Sector | Financial Services |
| Employees | 2 |
| CEO | Michael Hoffman |
Contact Details
52 E. 83rd Street New York City,
New York 10028 United States
Stock Details
| Ticker Symbol | TDAC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001926599 |
| CUSIP Number | G9008W105 |
| ISIN Number | KYG9008W1050 |
| SIC Code | 6770 |
Add to Watchlist
Select watchlists to add or remove TDAC